Bugs boost wine aroma
A new strain of the enzyme ß-glucosidase isolated from the microbial strain Aureobasidium pullulans (Sp? ß-gl) improves the aroma of wine, according to a team of Brazilian researchers.1
A new strain of the enzyme ß-glucosidase isolated from the microbial strain Aureobasidium pullulans (Sp– ß-gl) improves the aroma of wine, according to a team of Brazilian researchers.1 Published in Appl. Biochem Biotechnol., the study indicated that the Sp– ß-gl strain functioned over a wide range of pH levels, had two peaks of optimum temperature and was tolerant to ethanol.
The aroma of wine is made up of volatile organic compounds (VOCs) and enzymatic treatment can release VOCs bound to sugars in wine to increase the aroma. One key class of flavouring compounds, glycosides, specifically terpenes (linalool, geraniol and nerol), are bound to sugar within the wine. Hydrolysis by enzyme treatment can free the sugar, releasing free terpenols. A significant increase of the level of free terpenols (linalool, geraniol and nerol) was identified using gas chromatography–mass spectrometry (GC–MS), validating the use of Sp– ß-gl in the improvement of wine aroma.
Scientists and winemakers have studied the microbial ecosystem within wine for some time. Societies of microbes exist within wine, and the relationships between different strains can be studied within this medium. These relationships are important to winemakers because they can change the composition and taste.
Traditionally, ß-glucosidase derived from fungus was used to improve aroma, however, this can result in the hydrolysis of anthocyanins producing aglycones, which are potentially toxic. Therefore, new strains of microbial enzymes for wine production are always in demand.
Reference
1. M. Baffi, T. Tobal, J. Lago, M. Boscolo, E. Gomes and Roberto Da-Silva, Appl Biochem Biotechnol, DOI: 10.1007/S12010-012-9991-2 (2012).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
